Dr. Oliver Braubach is a biologist and imaging specialist whose work bridges cellular and systems biology, advanced microscopy, and spatial proteomics. He currently serves as Director of Research & Development at Bruker Spatial Biology, where he leads the scientific team responsible for development of the CellScape™ precise spatial phenotyping platform and related multiplexed antibody assays. His group focuses on enabling comprehensive, cellular-resolution biomarker mapping for applications in oncology, neuroscience, and translational research. Oliver completed his Ph.D in Physiology and Neuroscience at Dalhousie University in Halifax, Canada. He has held multiple postdoctoral positions and industry positions. To date, Oliver authored or co-authored over 45 peer-reviewed publications and multiple patents spanning neuroscience, imaging, cancer biology, and spatial proteomics. Oliver’s current focus is on expanding the boundaries of quantitative, spatially resolved Spatial Biology - developing systems that integrate optics, immunofluorescence, and advanced bioinformatics to uncover cellular context in complex tissues. His long-term goal is to democratize high-plex imaging for both discovery research and clinical translation.